APO Research
Talk to an analyst

APO RESEARCH · REPORT

Implantable Neurostimulation Devices

Neurostimulation is a therapeutic activation of part of the nervous system using microelectrodes. The electrodes are used to interface with excitable tissue in order to either restore sensation, such as a cochlear implant for hearing, or control anorgan, such as a heart pacemaker.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Neurostimulation is a therapeutic activation of part of the nervous system using microelectrodes. The electrodes are used to interface with excitable tissue in order to either restore sensation, such as a cochlear implant for hearing, or control anorgan, such as a heart pacemaker.

Neurostimulation technology improves the life quality of those who are severely paralyzed or suffering from profound losses to various sense organs. It serves as the key part of neural prosthetics for hearing aids, artificial vision, artificial limbs, and brain-machine interfaces. In the case of neural stimulation, mostly an electrical stimulation is utilized and charge-balanced biphasic constant current waveforms of capacitive coupled charge injection approaches are adopted. Alternatively, the transcranial magnetic stimulation has been proposed as a non-invasive method in which a magnetic field causes neurostimulation.

Neurostimulation devices are implantable devices that help in the therapeutic activation of the nervous systems. These devices deliver electrical stimulation to the brain and nervous systems for the treatment of various types of neurological disorders such as pain, epilepsy, Parkinson's disease, depression, obsessive-compulsive disorder, dystonia, and tremors. These devices target specific areas of the brain or spinal cord by blocking the pain messages before they reach the brain.

Selected research

Industry Growth & Trends

Global Implantable Neurostimulation Devices Industry Growth and Trends Forecast to 2032

21 December 202599 pages

Choose your research edition.

Industry ResearchImplantable Neurostimulation Devices Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Implantable Neurostimulation Devices Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Implantable Neurostimulation Devices Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Implantable Neurostimulation Devices Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Implantable Neurostimulation Devices Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

Neurostimulation is a therapeutic activation of part of the nervous system using microelectrodes. The electrodes are used to interface with excitable tissue in order to either restore sensation, such as a cochlear implant for hearing, or control anorgan, such as a heart pacemaker.

Neurostimulation technology improves the life quality of those who are severely paralyzed or suffering from profound losses to various sense organs. It serves as the key part of neural prosthetics for hearing aids, artificial vision, artificial limbs, and brain-machine interfaces. In the case of neural stimulation, mostly an electrical stimulation is utilized and charge-balanced biphasic constant current waveforms of capacitive coupled charge injection approaches are adopted. Alternatively, the transcranial magnetic stimulation has been proposed as a non-invasive method in which a magnetic field causes neurostimulation.

Neurostimulation devices are implantable devices that help in the therapeutic activation of the nervous systems. These devices deliver electrical stimulation to the brain and nervous systems for the treatment of various types of neurological disorders such as pain, epilepsy, Parkinson's disease, depression, obsessive-compulsive disorder, dystonia, and tremors. These devices target specific areas of the brain or spinal cord by blocking the pain messages before they reach the brain.

Read the full market overview

Global Implantable Neurostimulation Devices key players include Medtronic, Boston Scientific, St. Jude Medical (Abbott), etc. Global top three manufacturers hold a share over 75%.

North America is the largest market, with a share over 80%, followed by Europe, and Asia (Ex.China), both have a share about 10 percent.

In terms of product, Spinal Cord Stimulation (SCS) is the largest segment, with a share over 55%. And in terms of application, the largest application is Pain Management, followed by Parkinson’s Disease, Epilepsy, Urinary and Fecal Incontinence, etc.

Report Scope

This report provides a structured, data-driven view of the global Implantable Neurostimulation Devices market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Implantable Neurostimulation Devices market size, estimates, and forecasts are presented in terms of sales volume (Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Implantable Neurostimulation Devices market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Implantable Neurostimulation Devices.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Implantable Neurostimulation Devices market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Implantable Neurostimulation Devices Market by Company

Medtronic

Boston Scientific

St. Jude Medical (Abbott)

LivaNova

Nevro

NeuroPace

Beijing Pins

Synapse Biomedical

Implantable Neurostimulation Devices Segment by Type

Spinal Cord Stimulation (SCS)

Gastric Electric Stimulation (GES)

Deep Brain Stimulation (DBS)

Sacral Nerve Stimulation (SNS)

Vagus Nerve Stimulation (VNS)

Others

Implantable Neurostimulation Devices Segment by Application

Pain Management

Parkinson's Disease

Urinary and Fecal Incontinence

Epilepsy

Gastroparesis

Others

Implantable Neurostimulation Devices Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Implantable Neurostimulation Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Implantable Neurostimulation Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Implantable Neurostimulation Devices.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Implantable Neurostimulation Devices manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Implantable Neurostimulation Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Spinal Cord Stimulation (SCS) Table 2. Major Company of Gastric Electric Stimulation (GES) Table 3. Major Company of Deep Brain Stimulation (DBS) Table 4. Major Company of Sacral Nerve Stimulation (SNS) Table 5. Major Company of Vagus Nerve Stimulation (VNS) Table 6. Major Company of Others Table 7. Global Implantable Neurostimulation Devices Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 8. Global Implantable Neurostimulation Devices Sales by Type (2021-2026) & (Units) Table 9. Global Implantable Neurostimulation Devices Sales Market Share in Volume by Type (2021-2026) Table 10. Global Implantable Neurostimulation Devices Sales by Type (2021-2026) & (US$ Million) Table 11. Global Implantable Neurostimulation Devices Sales Market Share in Value by Type (2021-2026) Table 12. Global Implantable Neurostimulation Devices Price by Type (2021-2026) & (K USD/Unit) Table 13. Global Implantable Neurostimulation Devices Sales by Type (2027-2032) & (Units) Table 14. Global Implantable Neurostimulation Devices Sales Market Share in Volume by Type (2027-2032) Table 15. Global Implantable Neurostimulation Devices Sales by Type (2027-2032) & (US$ Million) Table 16. Global Implantable Neurostimulation Devices Sales Market Share in Value by Type (2027-2032) Table 17. Global Implantable Neurostimulation Devices Price by Type (2027-2032) & (K USD/Unit) Table 18. North America Implantable Neurostimulation Devices Sales by Type (2021-2026) & (Units) Table 19. North America Implantable Neurostimulation Devices Sales by Type (2021-2026) & (US$ Million) Table 20. Europe Implantable Neurostimulation Devices Sales by Type (2021-2026) & (Units) Table 21. Europe Implantable Neurostimulation Devices Sales by Type (2021-2026) & (US$ Million) Table 22. Asia-Pacific Implantable Neurostimulation Devices Sales by Type (2021-2026) & (Units) Table 23. Asia-Pacific Implantable Neurostimulation Devices Sales by Type (2021-2026) & (US$ Million) Table 24. Latin America Implantable Neurostimulation Devices Sales by Type (2021-2026) & (Units) Table 25. Latin America Implantable Neurostimulation Devices Sales by Type (2021-2026) & (US$ Million) Table 26. Middle East and Africa Implantable Neurostimulation Devices Sales by Type (2021-2026) & (Units) Table 27. Middle East and Africa Implantable Neurostimulation Devices Sales by Type (2021-2026) & (US$ Million) Table 28. Implantable Neurostimulation Devices Industry Trends Table 29. Implantable Neurostimulation Devices Industry Drivers Table 30. Implantable Neurostimulation Devices Industry Opportunities and Challenges Table 31. Implantable Neurostimulation Devices Industry Restraints Table 32. Global Implantable Neurostimulation Devices Sales Revenue by Company (US$ Million) & (2021-2026) Table 33. Global Implantable Neurostimulation Devices Revenue Market Share by Company (2021-2026) Table 34. Global Implantable Neurostimulation Devices Sales by Company (2021-2026) & (Units) Table 35. Global Implantable Neurostimulation Devices Sales Share by Company (2021-2026) Table 36. Global Implantable Neurostimulation Devices Market Price by Company (2021-2026) & (K USD/Unit) Table 37. Global Implantable Neurostimulation Devices Industry Company Ranking, 2024 VS 2025 VS 2026 Table 38. Global Implantable Neurostimulation Devices Major Company Production Sites and Headquarters Table 39. Global Implantable Neurostimulation Devices Company, Product Type & Application Table 40. Global Implantable Neurostimulation Devices Company Establishment Date Table 41. Global Company Market Concentration Ratio (CR5 and HHI) Table 42. Global Implantable Neurostimulation Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 43. Global Implantable Neurostimulation Devices Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 44. Global Implantable Neurostimulation Devices Sales by Region (2021-2026) & (Units) Table 45. Global Implantable Neurostimulation Devices Sales Market Share in Volume by Region (2021-2026) Table 46. Global Implantable Neurostimulation Devices Sales by Region (2021-2026) & (US$ Million) Table 47. Global Implantable Neurostimulation Devices Sales Market Share in Value by Region (2021-2026) Table 48. Global Implantable Neurostimulation Devices Sales (Units), Value (US$ Million), Price (K USD/Unit) and Gross Margin (2021-2026) Table 49. Global Implantable Neurostimulation Devices Sales by Region (2027-2032) & (Units) Table 50. Global Implantable Neurostimulation Devices Sales Market Share in Volume by Region (2027-2032) Table 51. Global Implantable Neurostimulation Devices Sales by Region (2027-2032) & (US$ Million) Table 52. Global Implantable Neurostimulation Devices Sales Market Share in Value by Region (2027-2032) Table 53. Global Implantable Neurostimulation Devices Sales (Units), Value (US$ Million), Price (K USD/Unit) and Gross Margin (2027-2032) Table 54. Global Implantable Neurostimulation Devices Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 55. Global Implantable Neurostimulation Devices Sales by Application (2021-2026) & (Units) Table 56. Global Implantable Neurostimulation Devices Sales Market Share in Volume by Application (2021-2026) Table 57. Global Implantable Neurostimulation Devices Sales by Application (2021-2026) & (US$ Million) Table 58. Global Implantable Neurostimulation Devices Sales Market Share in Value by Application (2021-2026) Table 59. Global Implantable Neurostimulation Devices Price by Application (2021-2026) & (K USD/Unit) Table 60. Global Implantable Neurostimulation Devices Sales by Application (2027-2032) & (Units) Table 61. Global Implantable Neurostimulation Devices Sales Market Share in Volume by Application (2027-2032) Table 62. Global Implantable Neurostimulation Devices Sales by Application (2027-2032) & (US$ Million) Table 63. Global Implantable Neurostimulation Devices Sales Market Share in Value by Application (2027-2032) Table 64. Global Implantable Neurostimulation Devices Price by Application (2027-2032) & (K USD/Unit) Table 65. North America Implantable Neurostimulation Devices Sales by Application (2021-2026) & (Units) Table 66. North America Implantable Neurostimulation Devices Sales by Application (2021-2026) & (US$ Million) Table 67. Europe Implantable Neurostimulation Devices Sales by Application (2021-2026) & (Units) Table 68. Europe Implantable Neurostimulation Devices Sales by Application (2021-2026) & (US$ Million) Table 69. Asia-Pacific Implantable Neurostimulation Devices Sales by Application (2021-2026) & (Units) Table 70. Asia-Pacific Implantable Neurostimulation Devices Sales by Application (2021-2026) & (US$ Million) Table 71. Latin America Implantable Neurostimulation Devices Sales by Application (2021-2026) & (Units) Table 72. Latin America Implantable Neurostimulation Devices Sales by Application (2021-2026) & (US$ Million) Table 73. Middle East and Africa Implantable Neurostimulation Devices Sales by Application (2021-2026) & (Units) Table 74. Middle East and Africa Implantable Neurostimulation Devices Sales by Application (2021-2026) & (US$ Million) Table 75. Medtronic Company Information Table 76. Medtronic Business Overview Table 77. Medtronic Implantable Neurostimulation Devices Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2021-2026) Table 78. Medtronic Implantable Neurostimulation Devices Product Portfolio Table 79. Medtronic Recent Development Table 80. Boston Scientific Company Information Table 81. Boston Scientific Business Overview Table 82. Boston Scientific Implantable Neurostimulation Devices Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2021-2026) Table 83. Boston Scientific Implantable Neurostimulation Devices Product Portfolio Table 84. Boston Scientific Recent Development Table 85. St. Jude Medical (Abbott) Company Information Table 86. St. Jude Medical (Abbott) Business Overview Table 87. St. Jude Medical (Abbott) Implantable Neurostimulation Devices Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2021-2026) Table 88. St. Jude Medical (Abbott) Implantable Neurostimulation Devices Product Portfolio Table 89. St. Jude Medical (Abbott) Recent Development Table 90. LivaNova Company Information Table 91. LivaNova Business Overview Table 92. LivaNova Implantable Neurostimulation Devices Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2021-2026) Table 93. LivaNova Implantable Neurostimulation Devices Product Portfolio Table 94. LivaNova Recent Development Table 95. Nevro Company Information Table 96. Nevro Business Overview Table 97. Nevro Implantable Neurostimulation Devices Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2021-2026) Table 98. Nevro Implantable Neurostimulation Devices Product Portfolio Table 99. Nevro Recent Development Table 100. NeuroPace Company Information Table 101. NeuroPace Business Overview Table 102. NeuroPace Implantable Neurostimulation Devices Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2021-2026) Table 103. NeuroPace Implantable Neurostimulation Devices Product Portfolio Table 104. NeuroPace Recent Development Table 105. Beijing Pins Company Information Table 106. Beijing Pins Business Overview Table 107. Beijing Pins Implantable Neurostimulation Devices Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2021-2026) Table 108. Beijing Pins Implantable Neurostimulation Devices Product Portfolio Table 109. Beijing Pins Recent Development Table 110. Synapse Biomedical Company Information Table 111. Synapse Biomedical Business Overview Table 112. Synapse Biomedical Implantable Neurostimulation Devices Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2021-2026) Table 113. Synapse Biomedical Implantable Neurostimulation Devices Product Portfolio Table 114. Synapse Biomedical Recent Development Table 115. North America Implantable Neurostimulation Devices Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 116. North America Implantable Neurostimulation Devices Sales by Country (2021-2026) & (Units) Table 117. North America Implantable Neurostimulation Devices Sales Market Share by Country (2021-2026) Table 118. North America Implantable Neurostimulation Devices Sales Forecast by Country (2027-2032) & (Units) Table 119. North America Implantable Neurostimulation Devices Sales Market Share Forecast by Country (2027-2032) Table 120. North America Implantable Neurostimulation Devices Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 121. North America Implantable Neurostimulation Devices Market Size by Country (2021-2026) & (US$ Million) Table 122. North America Implantable Neurostimulation Devices Market Share by Country (2021-2026) Table 123. North America Implantable Neurostimulation Devices Market Size Forecast by Country (2027-2032) & (US$ Million) Table 124. North America Implantable Neurostimulation Devices Market Share Forecast by Country (2027-2032) Table 125. Europe Implantable Neurostimulation Devices Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 126. Europe Implantable Neurostimulation Devices Sales by Country (2021-2026) & (Units) Table 127. Europe Implantable Neurostimulation Devices Sales Market Share by Country (2021-2026) Table 128. Europe Implantable Neurostimulation Devices Sales Forecast by Country (2027-2032) & (Units) Table 129. Europe Implantable Neurostimulation Devices Sales Market Share Forecast by Country (2027-2032) Table 130. Europe Implantable Neurostimulation Devices Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 131. Europe Implantable Neurostimulation Devices Market Size by Country (2021-2026) & (US$ Million) Table 132. Europe Implantable Neurostimulation Devices Market Share by Country (2021-2026) Table 133. Europe Implantable Neurostimulation Devices Market Size Forecast by Country (2027-2032) & (US$ Million) Table 134. Europe Implantable Neurostimulation Devices Market Share Forecast by Country (2027-2032) Table 135. Asia-Pacific Implantable Neurostimulation Devices Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 136. Asia-Pacific Implantable Neurostimulation Devices Sales by Country (2021-2026) & (Units) Table 137. Asia-Pacific Implantable Neurostimulation Devices Sales Market Share by Country (2021-2026) Table 138. Asia-Pacific Implantable Neurostimulation Devices Sales Forecast by Country (2027-2032) & (Units) Table 139. Asia-Pacific Implantable Neurostimulation Devices Sales Market Share Forecast by Country (2027-2032) Table 140. Asia-Pacific Implantable Neurostimulation Devices Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 141. Asia-Pacific Implantable Neurostimulation Devices Market Size by Country (2021-2026) & (US$ Million) Table 142. Asia-Pacific Implantable Neurostimulation Devices Market Share by Country (2021-2026) Table 143. Asia-Pacific Implantable Neurostimulation Devices Market Size Forecast by Country (2027-2032) & (US$ Million) Table 144. Asia-Pacific Implantable Neurostimulation Devices Market Share Forecast by Country (2027-2032) Table 145. Latin America Implantable Neurostimulation Devices Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 146. Latin America Implantable Neurostimulation Devices Sales by Country (2021-2026) & (Units) Table 147. Latin America Implantable Neurostimulation Devices Sales Market Share by Country (2021-2026) Table 148. Latin America Implantable Neurostimulation Devices Sales Forecast by Country (2027-2032) & (Units) Table 149. Latin America Implantable Neurostimulation Devices Sales Market Share Forecast by Country (2027-2032) Table 150. Latin America Implantable Neurostimulation Devices Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 151. Latin America Implantable Neurostimulation Devices Market Size by Country (2021-2026) & (US$ Million) Table 152. Latin America Implantable Neurostimulation Devices Market Share by Country (2021-2026) Table 153. Latin America Implantable Neurostimulation Devices Market Size Forecast by Country (2027-2032) & (US$ Million) Table 154. Latin America Implantable Neurostimulation Devices Market Share Forecast by Country (2027-2032) Table 155. Middle East and Africa Implantable Neurostimulation Devices Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 156. Middle East and Africa Implantable Neurostimulation Devices Sales by Country (2021-2026) & (Units) Table 157. Middle East and Africa Implantable Neurostimulation Devices Sales Market Share by Country (2021-2026) Table 158. Middle East and Africa Implantable Neurostimulation Devices Sales Forecast by Country (2027-2032) & (Units) Table 159. Middle East and Africa Implantable Neurostimulation Devices Sales Market Share Forecast by Country (2027-2032) Table 160. Middle East and Africa Implantable Neurostimulation Devices Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 161. Middle East and Africa Implantable Neurostimulation Devices Market Size by Country (2021-2026) & (US$ Million) Table 162. Middle East and Africa Implantable Neurostimulation Devices Market Share by Country (2021-2026) Table 163. Middle East and Africa Implantable Neurostimulation Devices Market Size Forecast by Country (2027-2032) & (US$ Million) Table 164. Middle East and Africa Implantable Neurostimulation Devices Market Share Forecast by Country (2027-2032) Table 165. Key Raw Materials Table 166. Raw Materials Key Suppliers Table 167. Implantable Neurostimulation Devices Distributors List Table 168. Implantable Neurostimulation Devices Customers List Table 169. Research Programs/Design for This Report Table 170. Authors List of This Report Table 171. Secondary Sources Table 172. Primary Sources List of Figures Figure 1. Implantable Neurostimulation Devices Image Figure 2. Global Implantable Neurostimulation Devices Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Implantable Neurostimulation Devices Market Size (2021-2032) & (US$ Million) Figure 4. Global Implantable Neurostimulation Devices Sales (2021-2032) & (Units) Figure 5. Spinal Cord Stimulation (SCS) Image Figure 6. Global Spinal Cord Stimulation (SCS) Sales YoY Growth (2021-2032) & (Units) Figure 7. Gastric Electric Stimulation (GES) Image Figure 8. Global Gastric Electric Stimulation (GES) Sales YoY Growth (2021-2032) & (Units) Figure 9. Deep Brain Stimulation (DBS) Image Figure 10. Global Deep Brain Stimulation (DBS) Sales YoY Growth (2021-2032) & (Units) Figure 11. Sacral Nerve Stimulation (SNS) Image Figure 12. Global Sacral Nerve Stimulation (SNS) Sales YoY Growth (2021-2032) & (Units) Figure 13. Vagus Nerve Stimulation (VNS) Image Figure 14. Global Vagus Nerve Stimulation (VNS) Sales YoY Growth (2021-2032) & (Units) Figure 15. Others Image Figure 16. Global Others Sales YoY Growth (2021-2032) & (Units) Figure 17. Global Implantable Neurostimulation Devices Market Size Overview by Type (2021-2032) & (US$ Million) Figure 18. Global Implantable Neurostimulation Devices Market Share by Type 2025 VS 2032 Figure 19. North America Implantable Neurostimulation Devices Sales Market Share in Volume by Type in 2025 Figure 20. North America Implantable Neurostimulation Devices Sales Market Share in Value by Type in 2025 Figure 21. Europe Implantable Neurostimulation Devices Sales Market Share in Volume by Type in 2025 Figure 22. Europe Implantable Neurostimulation Devices Sales Market Share in Value by Type in 2025 Figure 23. Asia-Pacific Implantable Neurostimulation Devices Sales Market Share in Volume by Type in 2025 Figure 24. Asia-Pacific Implantable Neurostimulation Devices Sales Market Share in Value by Type in 2025 Figure 25. Latin America Implantable Neurostimulation Devices Sales Market Share in Volume by Type in 2025 Figure 26. Latin America Implantable Neurostimulation Devices Sales Market Share in Value by Type in 2025 Figure 27. Middle East and Africa Implantable Neurostimulation Devices Sales Market Share in Volume by Type in 2025 Figure 28. Middle East and Africa Implantable Neurostimulation Devices Sales Market Share in Value by Type in 2025 Figure 29. Global Top 5 and 10 Implantable Neurostimulation Devices Players Market Share by Revenue in 2025 Figure 30. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Pain Management Image Figure 32. Global Pain Management Sales YoY Growth (2021-2032) & (Units) Figure 33. Parkinson's Disease Image Figure 34. Global Parkinson's Disease Sales YoY Growth (2021-2032) & (Units) Figure 35. Urinary and Fecal Incontinence Image Figure 36. Global Urinary and Fecal Incontinence Sales YoY Growth (2021-2032) & (Units) Figure 37. Epilepsy Image Figure 38. Global Epilepsy Sales YoY Growth (2021-2032) & (Units) Figure 39. Gastroparesis Image Figure 40. Global Gastroparesis Sales YoY Growth (2021-2032) & (Units) Figure 41. Others Image Figure 42. Global Others Sales YoY Growth (2021-2032) & (Units) Figure 43. Global Implantable Neurostimulation Devices Market Size Overview by Application (2021-2032) & (US$ Million) Figure 44. Global Implantable Neurostimulation Devices Market Share by Application 2025 VS 2032 Figure 45. North America Implantable Neurostimulation Devices Sales Market Share in Volume by Application in 2025 Figure 46. North America Implantable Neurostimulation Devices Sales Market Share in Value by Application in 2025 Figure 47. Europe Implantable Neurostimulation Devices Sales Market Share in Volume by Application in 2025 Figure 48. Europe Implantable Neurostimulation Devices Sales Market Share in Value by Application in 2025 Figure 49. Asia-Pacific Implantable Neurostimulation Devices Sales Market Share in Volume by Application in 2025 Figure 50. Asia-Pacific Implantable Neurostimulation Devices Sales Market Share in Value by Application in 2025 Figure 51. Latin America Implantable Neurostimulation Devices Sales Market Share in Volume by Application in 2025 Figure 52. Latin America Implantable Neurostimulation Devices Sales Market Share in Value by Application in 2025 Figure 53. Middle East and Africa Implantable Neurostimulation Devices Sales Market Share in Volume by Application in 2025 Figure 54. Middle East and Africa Implantable Neurostimulation Devices Sales Market Share in Value by Application in 2025 Figure 55. North America Implantable Neurostimulation Devices Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 56. North America Implantable Neurostimulation Devices Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. North America Implantable Neurostimulation Devices Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. North America Implantable Neurostimulation Devices Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Implantable Neurostimulation Devices Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 60. Europe Implantable Neurostimulation Devices Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Implantable Neurostimulation Devices Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Europe Implantable Neurostimulation Devices Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Implantable Neurostimulation Devices Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 64. Asia-Pacific Implantable Neurostimulation Devices Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Asia-Pacific Implantable Neurostimulation Devices Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Asia-Pacific Implantable Neurostimulation Devices Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Latin America Implantable Neurostimulation Devices Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 68. Latin America Implantable Neurostimulation Devices Sales Share by Country: 2021 VS 2025 VS 2032 Figure 69. Latin America Implantable Neurostimulation Devices Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 70. Latin America Implantable Neurostimulation Devices Market Share by Country: 2021 VS 2025 VS 2032 Figure 71. Middle East and Africa Implantable Neurostimulation Devices Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 72. Middle East and Africa Implantable Neurostimulation Devices Sales Share by Country: 2021 VS 2025 VS 2032 Figure 73. Middle East and Africa Implantable Neurostimulation Devices Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 74. Middle East and Africa Implantable Neurostimulation Devices Market Share by Country: 2021 VS 2025 VS 2032 Figure 75. Implantable Neurostimulation Devices Value Chain Figure 76. Key Raw Materials Price Figure 77. Manufacturing Cost Structure Figure 78. Implantable Neurostimulation Devices Production Mode & Process Figure 79. Direct Comparison with Distribution Share Figure 80. Distributors Profiles Figure 81. Years Considered Figure 82. Research Process Figure 83. Key Executives Interviewed

Scope & coverage.

Types
  • Spinal Cord Stimulation (SCS)
  • Gastric Electric Stimulation (GES)
  • Deep Brain Stimulation (DBS)
  • Sacral Nerve Stimulation (SNS)
  • Vagus Nerve Stimulation (VNS)
  • Others
Applications
  • Pain Management
  • Parkinson's Disease
  • Urinary and Fecal Incontinence
  • Epilepsy
  • Gastroparesis
  • Others
Companies covered
  • Medtronic
  • Boston Scientific
  • St. Jude Medical (Abbott)
  • LivaNova
  • Nevro
  • NeuroPace
  • Beijing Pins
  • Synapse Biomedical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Implantable Neurostimulation Devices Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Implantable Neurostimulation Devices Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Implantable Neurostimulation Devices Market by Type
  6. 1.3.1 Spinal Cord Stimulation (SCS)
  7. 1.3.2 Gastric Electric Stimulation (GES)
  8. 1.3.3 Deep Brain Stimulation (DBS)
  9. 1.3.4 Sacral Nerve Stimulation (SNS)
  10. 1.3.5 Vagus Nerve Stimulation (VNS)
  11. 1.3.6 Others
  12. 1.4 Global Implantable Neurostimulation Devices Market Size by Type
  13. 1.4.1 Global Implantable Neurostimulation Devices Market Size Overview by Type (2021-2032)
  14. 1.4.2 Global Implantable Neurostimulation Devices Historic Market Size Review by Type (2021-2026)
  15. 1.4.3 Global Implantable Neurostimulation Devices Forecasted Market Size by Type (2027-2032)
  16. 1.5 Key Regions Market Size by Type
  17. 1.5.1 North America Implantable Neurostimulation Devices Sales Breakdown by Type (2021-2026)
  18. 1.5.2 Europe Implantable Neurostimulation Devices Sales Breakdown by Type (2021-2026)
  19. 1.5.3 Asia-Pacific Implantable Neurostimulation Devices Sales Breakdown by Type (2021-2026)
  20. 1.5.4 South America Implantable Neurostimulation Devices Sales Breakdown by Type (2021-2026)
  21. 1.5.5 Middle East and Africa Implantable Neurostimulation Devices Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Implantable Neurostimulation Devices Industry Trends
  2. 2.2 Implantable Neurostimulation Devices Industry Drivers
  3. 2.3 Implantable Neurostimulation Devices Industry Opportunities and Challenges
  4. 2.4 Implantable Neurostimulation Devices Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Implantable Neurostimulation Devices Revenue (2021-2026)
  2. 3.2 Global Top Players by Implantable Neurostimulation Devices Sales (2021-2026)
  3. 3.3 Global Top Players by Implantable Neurostimulation Devices Price (2021-2026)
  4. 3.4 Global Implantable Neurostimulation Devices Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Implantable Neurostimulation Devices Major Company Production Sites & Headquarters
  6. 3.6 Global Implantable Neurostimulation Devices Company, Product Type & Application
  7. 3.7 Global Implantable Neurostimulation Devices Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Implantable Neurostimulation Devices Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Implantable Neurostimulation Devices Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Implantable Neurostimulation Devices Tier 1, Tier 2, and Tier 3
4 Implantable Neurostimulation Devices Regional Status and Outlook
  1. 4.1 Global Implantable Neurostimulation Devices Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Implantable Neurostimulation Devices Historic Market Size by Region
  3. 4.2.1 Global Implantable Neurostimulation Devices Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Implantable Neurostimulation Devices Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Implantable Neurostimulation Devices Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Implantable Neurostimulation Devices Forecasted Market Size by Region
  7. 4.3.1 Global Implantable Neurostimulation Devices Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Implantable Neurostimulation Devices Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Implantable Neurostimulation Devices Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Implantable Neurostimulation Devices by Application
  1. 5.1 Implantable Neurostimulation Devices Market by Application
  2. 5.1.1 Pain Management
  3. 5.1.2 Parkinson's Disease
  4. 5.1.3 Urinary and Fecal Incontinence
  5. 5.1.4 Epilepsy
  6. 5.1.5 Gastroparesis
  7. 5.1.6 Others
  8. 5.2 Global Implantable Neurostimulation Devices Market Size by Application
  9. 5.2.1 Global Implantable Neurostimulation Devices Market Size Overview by Application (2021-2032)
  10. 5.2.2 Global Implantable Neurostimulation Devices Historic Market Size Review by Application (2021-2026)
  11. 5.2.3 Global Implantable Neurostimulation Devices Forecasted Market Size by Application (2027-2032)
  12. 5.3 Key Regions Market Size by Application
  13. 5.3.1 North America Implantable Neurostimulation Devices Sales Breakdown by Application (2021-2026)
  14. 5.3.2 Europe Implantable Neurostimulation Devices Sales Breakdown by Application (2021-2026)
  15. 5.3.3 Asia-Pacific Implantable Neurostimulation Devices Sales Breakdown by Application (2021-2026)
  16. 5.3.4 South America Implantable Neurostimulation Devices Sales Breakdown by Application (2021-2026)
  17. 5.3.5 Middle East and Africa Implantable Neurostimulation Devices Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Medtronic
  2. 6.1.1 Medtronic Company Information
  3. 6.1.2 Medtronic Business Overview
  4. 6.1.3 Medtronic Implantable Neurostimulation Devices Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Medtronic Implantable Neurostimulation Devices Product Portfolio
  6. 6.1.5 Medtronic Recent Developments
  7. 6.2 Boston Scientific
  8. 6.2.1 Boston Scientific Company Information
  9. 6.2.2 Boston Scientific Business Overview
  10. 6.2.3 Boston Scientific Implantable Neurostimulation Devices Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Boston Scientific Implantable Neurostimulation Devices Product Portfolio
  12. 6.2.5 Boston Scientific Recent Developments
  13. 6.3 St. Jude Medical (Abbott)
  14. 6.3.1 St. Jude Medical (Abbott) Company Information
  15. 6.3.2 St. Jude Medical (Abbott) Business Overview
  16. 6.3.3 St. Jude Medical (Abbott) Implantable Neurostimulation Devices Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 St. Jude Medical (Abbott) Implantable Neurostimulation Devices Product Portfolio
  18. 6.3.5 St. Jude Medical (Abbott) Recent Developments
  19. 6.4 LivaNova
  20. 6.4.1 LivaNova Company Information
  21. 6.4.2 LivaNova Business Overview
  22. 6.4.3 LivaNova Implantable Neurostimulation Devices Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 LivaNova Implantable Neurostimulation Devices Product Portfolio
  24. 6.4.5 LivaNova Recent Developments
  25. 6.5 Nevro
  26. 6.5.1 Nevro Company Information
  27. 6.5.2 Nevro Business Overview
  28. 6.5.3 Nevro Implantable Neurostimulation Devices Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Nevro Implantable Neurostimulation Devices Product Portfolio
  30. 6.5.5 Nevro Recent Developments
  31. 6.6 NeuroPace
  32. 6.6.1 NeuroPace Company Information
  33. 6.6.2 NeuroPace Business Overview
  34. 6.6.3 NeuroPace Implantable Neurostimulation Devices Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 NeuroPace Implantable Neurostimulation Devices Product Portfolio
  36. 6.6.5 NeuroPace Recent Developments
  37. 6.7 Beijing Pins
  38. 6.7.1 Beijing Pins Company Information
  39. 6.7.2 Beijing Pins Business Overview
  40. 6.7.3 Beijing Pins Implantable Neurostimulation Devices Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Beijing Pins Implantable Neurostimulation Devices Product Portfolio
  42. 6.7.5 Beijing Pins Recent Developments
  43. 6.8 Synapse Biomedical
  44. 6.8.1 Synapse Biomedical Company Information
  45. 6.8.2 Synapse Biomedical Business Overview
  46. 6.8.3 Synapse Biomedical Implantable Neurostimulation Devices Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Synapse Biomedical Implantable Neurostimulation Devices Product Portfolio
  48. 6.8.5 Synapse Biomedical Recent Developments
7 North America by Country
  1. 7.1 North America Implantable Neurostimulation Devices Sales by Country
  2. 7.1.1 North America Implantable Neurostimulation Devices Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Implantable Neurostimulation Devices Sales by Country (2021-2026)
  4. 7.1.3 North America Implantable Neurostimulation Devices Sales Forecast by Country (2027-2032)
  5. 7.2 North America Implantable Neurostimulation Devices Market Size by Country
  6. 7.2.1 North America Implantable Neurostimulation Devices Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Implantable Neurostimulation Devices Market Size by Country (2021-2026)
  8. 7.2.3 North America Implantable Neurostimulation Devices Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Implantable Neurostimulation Devices Sales by Country
  2. 8.1.1 Europe Implantable Neurostimulation Devices Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Implantable Neurostimulation Devices Sales by Country (2021-2026)
  4. 8.1.3 Europe Implantable Neurostimulation Devices Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Implantable Neurostimulation Devices Market Size by Country
  6. 8.2.1 Europe Implantable Neurostimulation Devices Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Implantable Neurostimulation Devices Market Size by Country (2021-2026)
  8. 8.2.3 Europe Implantable Neurostimulation Devices Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Implantable Neurostimulation Devices Sales by Country
  2. 9.1.1 Asia-Pacific Implantable Neurostimulation Devices Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Implantable Neurostimulation Devices Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Implantable Neurostimulation Devices Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Implantable Neurostimulation Devices Market Size by Country
  6. 9.2.1 Asia-Pacific Implantable Neurostimulation Devices Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Implantable Neurostimulation Devices Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Implantable Neurostimulation Devices Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Implantable Neurostimulation Devices Sales by Country
  2. 10.1.1 South America Implantable Neurostimulation Devices Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Implantable Neurostimulation Devices Sales by Country (2021-2026)
  4. 10.1.3 South America Implantable Neurostimulation Devices Sales Forecast by Country (2027-2032)
  5. 10.2 South America Implantable Neurostimulation Devices Market Size by Country
  6. 10.2.1 South America Implantable Neurostimulation Devices Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Implantable Neurostimulation Devices Market Size by Country (2021-2026)
  8. 10.2.3 South America Implantable Neurostimulation Devices Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Implantable Neurostimulation Devices Sales by Country
  2. 11.1.1 Middle East and Africa Implantable Neurostimulation Devices Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Implantable Neurostimulation Devices Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Implantable Neurostimulation Devices Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Implantable Neurostimulation Devices Market Size by Country
  6. 11.2.1 Middle East and Africa Implantable Neurostimulation Devices Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Implantable Neurostimulation Devices Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Implantable Neurostimulation Devices Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Implantable Neurostimulation Devices Value Chain Analysis
  2. 12.1.1 Implantable Neurostimulation Devices Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Implantable Neurostimulation Devices Production Mode & Process
  7. 12.2 Implantable Neurostimulation Devices Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Implantable Neurostimulation Devices Distributors
  10. 12.2.3 Implantable Neurostimulation Devices Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst